Vivek Subbiah joined the Sarah Cannon Research Institute (SCRI) in 2023. Previously, he spent nearly 15 years at the University of Texas MD Anderson Cancer Center as an associate professor in the Department of Investigational Cancer Therapeutics. There, he held several leadership roles, including executive director of Medical Oncology Research and clinical medical director of the Division of Cancer Medicine, overseeing outpatient and inpatient clinical care delivery.
